Latest Institutional Placement News

Vitrafy Life Sciences has launched a non-underwritten Share Purchase Plan to raise approximately A$2 million, offering existing Australian and New Zealand shareholders the chance to buy shares at A$2.60 each, matching the recent institutional placement price.

Acrow Limited (ASX:ACF) is set to expand its Industrial Access and Construction Services footprint with a $54.5 million acquisition of Ausgroup and Preston SuperDeck, funded by a fully underwritten $70 million equity raise and a $10 million share purchase plan. The company also upgraded its FY27 revenue and EBITDA guidance by 21% and 15% respectively.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.

St George Mining has raised A$60 million through a two-tranche placement led by major shareholder Hancock Prospecting to accelerate development of its high-grade Araxá rare earths and niobium project in Brazil.

Southern Cross Electrical Engineering (ASX:SXE) has secured $150 million through a fully underwritten institutional placement priced at $4.00 per share, aiming to support new contracts and potential acquisitions. A $15 million share purchase plan will follow, offering existing shareholders a chance to participate.

Electro Optic Systems (ASX:EOS) has dramatically expanded its Share Purchase Plan from $25 million to $40 million after receiving $95 million in applications, reflecting robust support from retail investors. Approximately 5 million new shares will be issued at $8.00 each, matching recent institutional pricing.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.

EBR Systems has kicked off a fully underwritten 1-for-2 entitlement offer priced at $0.38 per CDI, aiming to raise $85.6 million to accelerate commercialisation and manufacturing of its wireless cardiac pacing technology.

Alicanto Minerals (ASX:AQI) has secured A$30 million through an institutional placement to fund an aggressive drilling campaign at its Mt Henry Gold Project in Western Australia, boosting its cash reserves to about A$41 million ahead of a resource update later this year.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

Barton Gold has secured $25.9 million through an institutional placement, fully funding critical resource upgrades, feasibility studies, and drilling at its key South Australian gold and silver projects.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.